Precision Medicine

Precision Medicine

Recent strides in the understanding of the human genome, coupled with the integration of Genetic Testing in clinical practices, have ushered in a new epoch in Medical Science.

Presently, at the clinical frontier, we possess the capability to meticulously determine the degree of predisposition or the causal factors influencing the manifestation of any biochemical aberration (pathology).


The field of Precision Medicine is advancing through three sequential stages.

The inaugural phase encompasses the execution of Genetic Tests (DNA tests) and/or Specialized Metabolic Tests.

By employing Genetic Tests, polymorphisms (Single Nucleotide Polymorphisms or SNPs) and gene variants within well-established genes, substantiated through years of rigorous investigation, are scrutinized. This method facilitates the identification of the following:

  • The inherent susceptibility of individuals to manifest a specific disease prior to its clinical presentation.
  • The exact mechanisms governing the manifestation of the respective disease following its onset.

The analysis is executed utilizing a salivary specimen and is conducted as a singular event within an individual’s lifespan. The outcomes retain validity throughout the entirety of one’s life.


The second stage pertains to ‘translation’ (Translational Medicine), encompassing the elucidation of the findings.

Understanding the genetic predisposition of each individual to develop a specific disease enables the formulation of a tailored therapeutic strategy with the objective of preemptively averting the onset of the condition.

Likewise, elucidating the underlying causes of a particular condition enhances an efficient, precisely targeted therapeutic approach by formulating Rigorously Personalized Treatment Regimens.


The third and ultimate phase now encompasses the implementation of a meticulously personalized therapeutic strategy.

In the contemporary medical landscape, within the epoch of Precision Medicine, antiquated are all preceding methodologies grounded in generalized therapeutic approaches (one size fits all).

Via Genetic Testing, optimal therapeutic agents tailored to each individual are discerned, i.e., substances to which each organism exhibits superior responsiveness. This approach eliminates the need for patients to undergo trial-and-error experimentation to identify the most efficacious treatment for them.


Patients are now eligible to receive Precision Therapies, characterized by myriad benefits and advantages, including:

  • Developed following strategic planning.
  • They are personalized, targeted, and multifaceted.
  • They yield superior outcomes in terms of recovery. Thus, the therapeutic benefit for patients is maximized.
  • They reduce the rehabilitation time, as well as unnecessary discomfort and expenses compared to therapeutic regimens of the past.

These Strictly Personalized Therapeutic Approaches can be recommended in collaboration with relevant Medical Specialties, taking into account a plethora of data such as precise analyses, complete genetic history, the potential presence of underlying conditions, gender, patient’s age, dietary habits, and many other factors.

The quality of life for patients undergoing such therapeutic interventions is enhanced, their organism undergoes reorganization, and their physical and, consequently, mental reserves are strengthened. Moreover, after the completion of the treatment, the chances of disease relapse are reduced.

In this way, the therapeutic benefit for patients is optimized, concurrently minimizing superfluous hardships and treatment expenditures to the minimum extent possible.